Targeting reactive oxygen species in hypertension

Antioxidants and Redox Signaling

Volumn 10, Issue 6, 2008, Pages 1061-1077

  Delles, Christian ^a   Miller, William H ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ARTERIAL STIFFNESS; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; COMORBIDITY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 41349083103     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.2008     Document Type: Review

References (214)

1. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, and Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200-1207, 2004.
2. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RAJ, Murphy MP, and Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19: 1088-1095, 2005.
3. Al Benna S, Hamilton CA, McClure JD, Rogers PN, Berg GA, Ford I, Delles C, and Dominiczak AF. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26: 218-223, 2006.
4. Alexander MY, Brosnan MJ, Hamilton CA, Fennell JP, Beattie EC, Jardine E, Heistad DD, and Dominiczak AF. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP. Cardiovasc Res 47: 609-617, 2000.
5. Alp NJ and Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24: 413-420, 2004.
6. Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Harrison DG, and Quyyumi AA. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 47: 1005-1011, 2006.
7. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Liker H, and Hayek T . Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23: 423-433, 2004.
8. Barrios V, Calderon A, Navarro-Cid J, Lahera V, and Ruilope LM. N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients. Blood Press 11: 235-239, 2002.
9. Bates CJ, Walmsley CM, Prentice A, and Finch S. Does vitamin C reduce blood pressure? results of a large study of people aged 65 or older. J Hypertens 16: 925-932, 1998.
10. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, and Creager MA. Inhibition of protein kinase C beta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90: 107-111, 2002.
11. Beckman JS, Chen J, Ischiropoulos H, and Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol 233: 229-240, 1994.
12. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
13. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, and Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212, 2000.
14. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 297: 842-857, 2007.
15. Blacher J, Asmar R, Djane S, London GM, and Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33: 1111-1117, 1999.
16. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M , Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, and Lackner KJ. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349: 1605-1613, 2003.
17. Bleeke T, Zhang H, Madamanchi N, Patterson C, and Faber JE. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004.
18. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, and Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218, 2000.
19. Brosnan MJ, Hamilton CA, Graham D, Lygate CA, Jardine E, and Dominiczak AF. Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. J Hypertens 20: 281-286, 2002.
20. Cabassi A, Dumont EC, Girouard H, Bouchard JF, Le Jossec M, Lamontagne D, Besner JG, and de Champlain J. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 19: 1233-1244, 2001.
21. Callera GE, Tostes RC, Yogi A, Montezano AC, and Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms Clin Sci (Lond) 110: 243-253, 2006.
22. Carlsson CM, Pharo LM, Aeschlimann SE, Mitchell C, Underbakke G, and Stein JH. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults. Am Heart J 148: E11, 2004.
23. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, and Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164: 921-935, 2006.
24. Chan SH, Tai MH, Li CY, and Chan JY. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med 40: 2028-2039, 2006.
25. Chen PY and Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88: 1559-1567, 1991.
26. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J , Economou M, Papadimitriou L, and Stefanadis C. The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis 192: 169-176, 2007.
27. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, and Heistad DD. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 92: 461-468, 2003.
28. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, Schmidt HH, Lassegue B, and Griendling KK. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27: 42-48, 2007.
29. Cockcroft JR, Chowienczyk PJ, Benjamin N, and Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 330: 1036-1040, 1994.
30. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, and Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 101:1530-1537, 1998.
31. Czernichow S, Bertrais S, Blacher J, Galan P, Briancon S, Favier A, Safar M, and Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens 23: 2013-2018, 2005.
32. Darley-Usmar V, Wiseman H, and Halliwell B. Nitric oxide and oxygen radicals, a question of balance. FEBS Lett 369: 13-15, 1995.
33. Delles C, Braga Marcano AC, Munroe PB, Padmanabhan S, McClure JD, Brain NJ, Browm MJ, Samani NJ, Clayton D, Farrall M, Webster J, Connell JMC, Caulfield MJ, and Dominiczak AF. Association between variants of the human GSTM gene family and hypertension. Hypertension 48: e27, 2006 (abstract).
34. Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, and Schmieder RE . Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol Dial Transplant 19: 2513-2518, 2004.
35. Delles C, Zimmerli LU, McGrane DJ, McKay AJ, Pathi VL, Dargie HJ, Hamilton CA, and Dominiczak AF. Functional relationship between oxidative stress and vascular stiffness in humans. Hypertension 48: e54, 2006 (abstract).
36. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, and Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51: 1118-1124, 2002.
37. Deshpande NN, Sorescu D, Seshiah P, Ushio-Fukai M, Akers M, Yin Q, and Griendling KK. Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal 4: 845-854, 2002.
38. Di Filippo C, Cuzzocrea S, Rossi F, Marfella R, and D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics Cardiovasc Drug Rev 24: 77-87, 2006.
39. Dickinson DA, Moellering DR, Iles KE, Patel RP, Levonen AL, Wigley A, Darley-Usmar VM, and Forman HJ. Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 384: 527-537, 2003.
40. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, and Vita JA. Treatment of hypertension with ascorbic acid. Lancet 354: 2048-2049, 1999.
41. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, and Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27: 997-1002, 2006.
42. Engelhard YN, Gazer B, and Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 151: 100, 2006.
43. Erdei N, Toth A, Pasztor ET, Papp Z, Edes I, Koller A, and Bagi Z. High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol 291: H2107-H2115, 2006.
44. Farquharson CA, Butler R, Hill A, Belch JJ, and Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106: 221-226, 2002.
45. Fennell JP, Brosnan MJ, Frater AJ, Hamilton CA, Alexander MY, Nicklin SA, Heistad DD, Baker AH, and Dominiczak AF. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 9:110-117, 2002.
46. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, and Mischak H. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18: 1057-1071, 2007.
47. Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 387: 1521-1533, 2006
48. Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, and Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22: 2169-2175, 2004.
49. Fotherby MD, Williams JC, Forster LA, Craner P, and Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 18: 411-415, 2000.
50. Fratta PA, Garbin U, Nava MC, Stranieri C, Davoli A, Sawamura T, Lo C, V, and Cominacini L. Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. J Hypertens 23: 589-596, 2005.
51. Freudenberger RS, Schwarz RP Jr, Brown J, Moore A, Mann D, Givertz MM, Colucci WS, and Hare JM. Rationale, design and organization of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III-IV congestive heart failure. Expert Opin Investig Drugs 13: 1509-1516, 2004.
52. Fridovich I. Superoxide anion radical, superoxide dismutases, and related matters. J Biol Chem 272: 18515-18517, 1997.
53. Frostegard J, Wu R, Lemne C, Thulin T, Witztum JL, and de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105: 615-620, 2003.
54. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q 4th, Taylor WR, Harrison DG, de Leon H, Wilcox JN, and Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1997.
55. Gale CR, Martyn CN, Winter PD, and Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310: 1563-1566, 1995.
56. Galisteo M, Garcia-Saura MF, Jimenez R, Villar IC, Zarzuelo A, Vargas F, and Duarte J. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol Cell Biochem 259: 91-99, 2004.
57. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, and Buring JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5: 255-260, 1995.
58. George J, Carr E, Davies J, Belch JJ, and Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114: 2508-2516, 2006.
59. George SJ, Channon KM, and Baker AH. Gene therapy and coronary artery bypass grafting: current perspectives. Curr Opin Mol Ther 8: 288-294, 2006.
60. Ghosh M, Wang HD, and McNeill JR. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol. 141: 562-573, 2004.
61. Gill PS and Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006.
62. Gillman MW, Cupples LA, Gagnon D, Posner BM, Ellison RC, Castelli WP, and Wolf PA. Protective effect of fruits and vegetables on development of stroke in men. JAMA 273: 1113-1117, 1995.
63. Graham D, Hamilton C, Beattie E, Spiers A, and Dominiczak AF. Comparison of the effects of omapatrilat and irbesartan/hydrochlorothiazide on endothelial function and cardiac hypertrophy in the stroke-prone spontaneously hypertensive rat: sex differences. J Hypertens 22: 329-337, 2004.
64. Griendling KK and FitzGerald GA. Oxidative stress and cardiovascular injury, Part II: animal and human studies. Circulation 108: 2034-2040, 2003.
65. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
66. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, and Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37: 549-554, 2005.
67. Guzik TJ and Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 11: 524-533, 2006.
68. Guzik TJ, Korbut R, and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469-487, 2003.
69. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
70. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, and Channon KM. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102: 1744-1747, 2000.
71. Hamilton CA, Miller WH, Al Benna S, Brosnan MJ, Drummond RD, McBride MW, and Dominiczak AF. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 106: 219-234, 2004.
72. Hamilton CA. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis. Pharmacol Ther 74: 55-72, 1997.
73. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 38: 171-196, 2006.
74. Heitzer T, Schlinzig T, Krohn K, Meinertz T, and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
75. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension . N Engl J Med 346: 1954-1962, 2002.
76. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538, 2002.
77. Hodgson JM, Puddey IB, Burke V, Beilin LJ, and Jordan N. Effects on blood pressure of drinking green and black tea. J Hypertens 17: 457-463, 1999.
78. Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR, Wilson RF, Cheng TY, Vassy J, Prokopowicz G, Barnes GJ 2nd, and Bass EB. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med 145: 372-385, 2006.
79. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, and Anderson TJ. The T-786→C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39: 919-922, 2002.
80. Jang YH, Lee YC, Park NH, Shin HY, Mun KC, Choi MS, Lee MY, Kim AR, Kim JM, Lee SR, and Park HR. Polyphenol (-)-epigallocatechin gallate protection from ischemia/reperfusion-induced renal injury in normotensive and hypertensive rats. Transplant Proc 38: 2190-2194, 2006.
81. Jeserich M, Schindler T, Olschewski M, Unmussig M, Just H, and Solzbach U. Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension assessed by cold pressor testing. Eur Heart J 20: 1676-1680, 1999.
82. John S, Delles C, Jacobi J, Schlaich MP, Schneider M, Schmitz G, and Schmieder RE. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol 37: 1351-1358, 2001.
83. John S, Schneider MP , Delles C, Jacobi J, and Schmieder RE. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 149: 473, 2005.
84. Kaminski PM and Wolin MS. Hypoxia increases superoxide anion production from bovine coronary microvessels, but not cardiac myocytes, via increased xanthine oxidase. Microcirculation 1: 231-236, 1994.
85. Kardinaal AF, Kok FJ , Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van't Veer P, Huttunen JK, and Martin-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet 342: 1379-1384, 1993.
86. Kardinaal AF, van 't Veer P, Brants HA, van den Berg H, van Schoonhoven J, and Hermus RJ. Relations between antioxidant vitamins in adipose tissue, plasma, and diet. Am J Epidemiol 141: 440-450, 1995.
87. Kashyap MK, Yadav V, Sherawat BS, Jain S, Kumari S, Khullar M, Sharma PC, and Nath R. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem 277: 89-99, 2005.
88. Katayama Y, Shige H, Yamamoto A, Hirata F, and Yasuda H. Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. J Atheroscler Thromb 11: 354-357, 2004.
89. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, and Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study: European prospective investigation into cancer and nutrition. Lancet 357: 657-663, 2001.
90. Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, and Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 39: 264-268, 2002.
91. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, Boeing H, Hofman A, Grobbee DE, and Witteman JC. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 69: 261-266, 1999.
92. Kong G, Lee S, and Kim KS. Inhibition of rac1 reduces PDGF-induced reactive oxygen species and proliferation in vascular smooth muscle cells. J Korean Med Sci. 16: 712-718, 2001.
93. Kurl S, Tuomainen TP , Laukkanen JA, Nyyssonen K, Lakka T, Sivenius J, and Salonen JT. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 33: 1568-1573, 2002.
94. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, and Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156-1162, 1996.
95. Laakso J, Mervaala E, Himberg JJ, Teravainen TL, Karppanen H, Vapaatalo H, and Lapatto R. Increased kidney xanthine oxido-reductase activity in salt-induced experimental hypertension. Hypertension 32: 902-906, 1998.
96. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
97. Landmesser U, Harrison DG, and Drexler H. Oxidant stress: a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur J Clin Pharmacol 62(suppl 1): 13-19, 2006.
98. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, and Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 101: 2264-2270, 2000.
99. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
100. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, and Struijker-Boudier H; European network for non-invasive investigation of large arteries: expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27: 2588-2605, 2006.
101. Lee SH, Oe T, and Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292: 2083-2086, 2001.
102. Lemne C, Jogestrand T, and de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 26: 34-39, 1995.
103. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, and Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93: 1107-1113, 1996.
104. Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei C, Williams GM, Liu DP, and Liang CC. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40: 1756-1775, 2006.
105. Li J, Li W, Su J, Liu W, Altura BT, and Altura BM. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes. Brain Res Bull 62: 101-106, 2003.
106. Li JM and Shah AM Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960, 2002.
107. Li JM and Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: role of the p47phox subunit. J Biol Chem 278: 12094-12100, 2003.
108. Li Q, Harraz MM, Zhou W, Zhang LN, Ding W, Zhang Y, Eggleston T, Yeaman C, Banfi B, and Engelhardt JF. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 26: 140-154, 2006.
109. Lin KF, Chao L, and Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 30: 307-313, 1997.
110. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, and Dagenais GR. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293: 1338-1347, 2005.
111. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, and Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 41: 422-430, 2003.
112. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Struber M, Haverich A, Bavendiek U, Drexler H, and Schieffer B. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 328: 183-188, 2005.
113. MacKenzie A, Filippini S, and Martin W. Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta. Br J Pharmacol 127: 1159-1164, 1999.
114. Mansego ML, Blesa S, Gonzalez-Albert V, Tormos MC, Saez G, Redon J, and Chaves FJ. Discordant response of glutathione and thioredoxin systems in human hypertension? Antioxid Redox Signal 9: 507-514, 2007.
115. Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, and Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 353: 344-350, 2007.
116. Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha M, Hui H, Yang G, Kennedy GC, Webster TA, Cawley S, Walsh PS, Jones KW, Fodor SP, and Mei R. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 1: 109-111, 2004.
117. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, Hanlon N, Hamilton CA, Polke JM, Lee WK, and Dominiczak AF. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 45: 786-792, 2005.
118. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, and Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension 41: 847-853, 2003.
119. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, and Hollenberg NK. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol 47(suppl 2): S103-S109, 2006.
120. McIlwain CC, Townsend DM, and Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648, 2006.
121. Melissas J, Malliaraki N, Papadakis JA, Taflampas P, Kampa M, and Castanas E. Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obesity Surg 16: 314-320, 2006.
122. Miller WH, Brosnan MJ, Graham D, Nicol CG, Morecroft I, Channon KM, Danilov SM, Reynolds PN, Baker AH, and Dominiczak AF. Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats. Mol Ther 12: 321-327, 2005.
123. Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, Li M, Raggio J, Wellstein A, Chen Y, Welch WJ, and Wilcox CS. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47: 238-244, 2006.
124. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signalling. Circ Res 90: E58-E65, 2002.
125. Moreno MU, Jose GS, Fortuno A, Beloqui O, Diez J, and Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 24: 1299-1306, 2006.
126. Mueller CF, Laude K, McNally JS, and Harrison DG. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25: 274-278, 2005.
127. Mugge A, Elwell JH, Peterson TE, and Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity, Am J Physiol 260: C219-C225, 1991.
128. Mullan BA, Young IS, Fee H, and McCance DR. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40: 804-809, 2002.
129. Murphy MP and Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47: 629-656, 2007.
130. Nickenig G, Strehlow K, Baumer AT, Baudler S, Wassmann S, Sauer H, and Böhm M. Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression. Br J Pharmacol 131: 795-803, 2000.
131. Nishio M, Sakata Y, Mano T, Yoshida J, Ohtani T, Takeda Y, Miwa T, Masuyama T, Yamamoto K, and Hori M. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure. J Hypertens 25: 455-461, 2007.
132. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, and Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22, 1999.
133. O'Rourke MF and Mancia G. Arterial stiffness. J Hypertens 17: 1-4, 1999.
134. Pannirselvam M, Simon V, Verma S, Anderson T, and Triggle CR. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140: 701-706, 2003.
135. Panza JA, Quyyumi AA , Brush JE Jr, and Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990.
136. Papaharalambus CA and Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17: 48-54, 2007.
137. Park J, Ha H, Ahn HJ, Kang SW, Kim YS, Seo JY, and Kim MS. Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells. Transplant Proc 37: 3459-3462, 2005.
138. Park JB, Touyz RM, Chen X, and Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded strokeprone spontaneously hypertensive rats. Am J Hypertens 15: 78-84, 2002.
139. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, and Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274: 19814-19822, 1999.
140. Pechanova O, Zicha J, Kojsova S, Dobesova Z, Jendekova L, and Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci (Lond) 110: 235-242, 2006.
141. Persu A, Vinck WJ, El Khattabi O, Janssen RG, Paulussen AD, Devuyst O, Vlietinck R, and Fagard RH. Influence of the endothelial nitric oxide synthase gene on conventional and ambulatory blood pressure: sib-pair analysis and haplotype study. J Hypertens 23: 759-765, 2005.
142. Peters PG, Alessio HM, Hagerman AE, Ashton T, Nagy S, and Wiley RL. Short-term isometric exercise reduces systolic blood pressure in hypertensive adults: possible role of reactive oxygen species. Int J Cardiol 110: 199-205, 2006.
143. Privratsky JR, Wold LE, Sowers JR, Quinn MT, and Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
144. Quintero M, Colombo SL, Godfrey A, and Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A 103: 5379-5384, 2006.
145. Rahman K and Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr 136: 736S-740S, 2006.
146. Rajagopalan S and Harrison DG. Reversing endothelial dysfunction with ace inhibitors: a new trend. Circulation 94: 240-243, 1996.
147. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 98: 2572-2579, 1996.
148. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, and Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003.
149. - and systolic blood pressure in mice, Circ Res 89: 408-414, 2001.
150. Rimm EB, Stampfer MJ , Ascherio A, Giovannucci E, Colditz GA, and Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450-1456, 1993.
151. Rueckschloss U, Galle J, Holtz J, Zerkowski HR, and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104: 1767-1772, 2001.
152. Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, and Redon J. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens 17: 809-816, 2004.
153. Salonen R and Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 229: 225-231, 1991.
154. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, and Poulsen HE. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107: 947-953, 2003.
155. Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Perez-Vizcaino F, and Duarte J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24: 75-84, 2006.
156. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
157. Schiffer E, Mischak H, and Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 6: 5615-5627, 2006.
158. Schlaich MP, Ahlers BA, Parnell MM, and Kaye DM. β-Adrenoceptor- mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine. J Hypertens 22: 1917-1925, 2004.
159. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ, and Kaye DM. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 110: 3680-3686, 2004.
160. Schneider MP, Delles C, Fleischmann E, Schmidt BM , John S, and Schmieder RE. Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia. Am J Cardiol 91: 482-484, 2003.
161. Schneider MP, Delles C, Schmidt BM, Oehmer S, Schwarz TK, Schmieder RE, and John S. Superoxide scavenging effects of Nacetylcysteine and vitamin C in subjects with essential hypertension. Am J Hypertens 18: 1111-1117, 2005.
162. Schneider MP, Klingbeil AU, Delles C, Schmidt BM, John S, and Schmieder RE. Vitamin C augments the renal response to L-arginine in smokers. Nephrol Dial Transplant 18: 1512-1517, 2003.
163. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
164. Sherman DL, Keaney JF Jr, Biegelsen ES, Duffy SJ , Coffman JD, and Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35: 936-941, 2000.
165. Skyrme-Jones RA, O'Brien RC, Berry KL, and Meredith IT. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 36: 94-102, 2000.
166. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, and Willett WC. Vitamin E consumption and the risk of coronary disease in women . N Engl J Med 328: 1444-1449, 1993.
167. Stiefel P, Arguelles S, Garcia S, Jimenez L, Aparicio R, Carneado J, Machado A, and Ayala A. Effects of short-term supplementation with folic acid on different oxidative stress parameters in patients with hypertension. Biochim Biophys Acta 1726: 152-159, 2005.
168. Struthers AD, Donnan PT, Lindsay P, McNaughton D, Broomhall J, and MacDonald TM. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 87: 229-234, 2002.
169. Sugiyama M, Ohashi M , Takase H, Sato K, Ueda R, and Dohi Y. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 20: 133-136, 2005.
170. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
171. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140: 105-112, 2003.
172. Taddei S, Virdis A, Ghiadoni L, Magagna A, and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
173. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, and Salvetti A. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 37: 943-948, 2001.
174. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, and Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279, 2001.
175. Tai MH, Hsiao M, Chan JY, Lo WC, Wang FS, Liu GS, Howng SL, and Tseng CJ. Gene delivery of endothelial nitric oxide synthase into nucleus tractus solitarii induces biphasic response in cardiovascular functions of hypertensive rats. Am J Hypertens 17: 63-70, 2004.
176. Takemoto M and Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21: 1712-1719, 2001.
177. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003.
178. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, and Rosenkranz S. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71: 331-341, 2006.
179. Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, and Manning RD Jr. N-acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 24: 2263-2270, 2006.
180. Torrecillas G, Boyano-Adanez MC, Medina J, Parra T, Griera M, Lopez-Ongil S, Arilla E, Rodriguez-Puyol M, and Rodriguez-Puyol D. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 9: 104-112, 2001.
181. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, and Schiffrin EL. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81: 159-167, 2003.
182. Touyz RM and Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339-352, 2004.
183. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252, 2004.
184. Tuck ML, Sowers J, Dornfeld L, Kledzik G, and Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304: 930-933, 1981.
185. Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, and Nemeth I. Oxidative stress in juvenile essential hypertension. J Hypertens 21: 145-152, 2003.
186. Turrens JF. Mitochondrial formation of reactive oxygen species J Physiol 552: 335-344, 2003.
187. Upston JM, Terentis AC, Morris K, Keaney JF Jr, and Stocker R. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem J 363: 753-760, 2002.
188. Vasankari T, Ahotupa M, Toikka J, Mikkola J, Irjala K, Pasanen P, Neuvonen K, Raitakari O, and Viikari J. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 155: 403-412, 2001.
189. Vera R, Sanchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Perez-Vizcaino F, and Duarte J. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci (Lond) 112: 183-191, 2007.
190. Violi F, Loffredo L, Musella L, and Marcoccia A. Should antioxidant status be considered in interventional trials with antioxidants? Heart 90: 598-602, 2004.
191. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, and Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361: 2017-2023, 2003.
192. Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, and Hodgson JM. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25: 227-234, 2007.
193. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Böhm M, and Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22: 300-305, 2002.
194. Wassmann S, Ribaudo N, Faul A, Laufs U, Bohm M, and Nickenig G. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum lowdensity lipoprotein cholesterol levels <130 mg/dl. Am J Cardiol 93: 84-88, 2004.
195. Watanabe T, Yasunari K, Nakamura M, and Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens 20: 336-340, 2006.
196. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drueke TB, Lacour B, and Massy ZA. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 6: 993-1000, 2006.
197. Welch WJ, Mendonca M, Blau J, Karber A, Dennehy K, Patel K, Lao YS, Jose PA, and Wilcox CS. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 68: 179-187, 2005.
198. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005.
199. Wilkinson IB, Megson IL, MacCallum H, Sogo N, Cockcroft JR, and Webb DJ. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34: 690-693, 1999.
200. Wykretowicz A, Guzik P, Kasinowski R, Krauze T, Bartkowiak G, Dziarmaga M, and Wysocki H. Augmentation index, pulse pressure amplification and superoxide anion production in patients with coronary artery disease. Int J Cardiol 99: 289-294, 2005.
201. Xu JW, Ikeda K, and Yamori Y. Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27: 675-683, 2004.
202. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, and Kajiya F. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107: 1040-1045, 2003.
203. Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, Dong YF, Matsuba S, Ogawa H, and Kim-Mitsuyama S. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol 27: 556-563, 2007.
204. Yamamoto Y and Oue E. Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem 70: 933-939, 2006.
205. Yamamoto Y, Ogino K, Igawa G, Matsuura T, Kaetsu Y, Sugihara S, Matsubara K, Miake J, Hamada T, Yoshida A, Igawa O, Yamamoto T, Shigemasa C, and Hisatome I. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Hypertens Res 29: 915-921, 2006.
206. Zalba G, Beloqui O, San Jose G, Moreno MU, Fortuno A, and Diez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 25: 1452-1457, 2005.
207. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 98: 24-27, 2002.
208. Zhan CD, Sindhu RK, Pang J, Ehdaie A, and Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens 22: 2025-2033, 2004.
209. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, Mc-Donald MM, Humphrey JD, and Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 44: 935-943, 2004.
210. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, Sessa WC, and Min W. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 170: 1108-1120, 2007.
211. Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G, Kovesdi I, and Chen AF. Gene transfer of human guanosine 5-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108: 1238-1245, 2003.
212. Zimmerman MC and Davisson RL Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 84: 125-149, 2004.
213. Zimmerman MC, Lazartigues E, Sharma RV, and Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.
214. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, and Hercberg S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24: 1485-1491, 2004.